A less toxic, solvent-free chemotherapy drug more effectively prevents the progression of metastatic breast cancer and has fewer side effects than a commonly used solvent-based drug. Abraxane prolonged progression-free survival by almost seven months compared with Taxotere, which is part of a class of solvent-based drugs called taxanes.
Full article >>
Wednesday, May 27, 2009
Less-toxic Drug Prolongs Survival In Metastatic Breast Cancer
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment